Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of American College Health : J of ACH
|
June 29, 2018
Building a health communication brand for University of Texas System tobacco control
Michael Mackert, Kathleen Case, Allison Lazard, et al.
Frontiers in Public Health
|
December 31, 2021
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey
Melissa A Valerio-Shewmaker, Stacia DeSantis, Michael Swartz, et al.
Plos One
|
May 13, 2024
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample
Ashraf Yaseen, Stacia M DeSantis, Rachit Sabharwal, et al.
Children (Basel, Switzerland)
|
May 27, 2023
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents
Sarah E Messiah, Michael D Swartz, Rhiana A Abbas, et al.
Pediatric Research
|
October 24, 2023
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents
Sarah E Messiah, Yashar Talebi, Michael D Swartz, et al.
The Pediatric Infectious Disease Journal
|
August 8, 2022
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents
Sarah E Messiah, Tianyao Hao, Stacia M DeSantis, et al.
Open Forum Infectious Diseases
|
December 15, 2023
RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023
Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
The Journal of Infectious Diseases
|
February 2, 2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants
Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
Plos One
|
September 9, 2022
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region
Stacia M DeSantis, Luis G León-Novelo, Michael D Swartz, et al.
Frontiers in Pediatrics
|
September 4, 2024
Factors associated with elevated SARS-CoV-2 immune response in children and adolescents
Sarah E Messiah, Rhiana Abbas, Emma Bergqvist, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of American College Health : J of ACH
|
June 29, 2018
Building a health communication brand for University of Texas System tobacco control
Michael Mackert, Kathleen Case, Allison Lazard, et al.
Frontiers in Public Health
|
December 31, 2021
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey
Melissa A Valerio-Shewmaker, Stacia DeSantis, Michael Swartz, et al.
Plos One
|
May 13, 2024
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample
Ashraf Yaseen, Stacia M DeSantis, Rachit Sabharwal, et al.
Children (Basel, Switzerland)
|
May 27, 2023
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents
Sarah E Messiah, Michael D Swartz, Rhiana A Abbas, et al.
Pediatric Research
|
October 24, 2023
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents
Sarah E Messiah, Yashar Talebi, Michael D Swartz, et al.
The Pediatric Infectious Disease Journal
|
August 8, 2022
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents
Sarah E Messiah, Tianyao Hao, Stacia M DeSantis, et al.
Open Forum Infectious Diseases
|
December 15, 2023
RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023
Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
The Journal of Infectious Diseases
|
February 2, 2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants
Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
Plos One
|
September 9, 2022
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region
Stacia M DeSantis, Luis G León-Novelo, Michael D Swartz, et al.
Frontiers in Pediatrics
|
September 4, 2024
Factors associated with elevated SARS-CoV-2 immune response in children and adolescents
Sarah E Messiah, Rhiana Abbas, Emma Bergqvist, et al.
Page
of 3